This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Daniel J Von Seggern
Introduction
Daniel J Von Seggern is a notable inventor based in San Diego, CA. He has made significant contributions to the field of gene therapy, particularly through his innovative work with adenovirus vectors. His research has implications for the development of targeted therapies that can improve patient outcomes.
Latest Patents
Daniel J Von Seggern holds a patent for "Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use." This invention relates to methods for gene therapy, especially adenovirus-based gene therapy. It includes novel nucleic acid constructs and packaging cell lines that facilitate the development of high-capacity and targeted vectors. The patent also discloses various high-capacity adenovirus vectors and related compositions, including kits that utilize the disclosed cell lines and vectors. Furthermore, it outlines methods for preparing and using these vectors, cell lines, and kits.
Career Highlights
Daniel J Von Seggern is affiliated with the Scripps Research Institute, where he has been involved in groundbreaking research. His work has contributed to advancements in gene therapy, showcasing his commitment to improving medical treatments through innovative technologies.
Collaborations
One of his notable collaborators is Glen R Nemerow, with whom he has worked on various projects related to adenovirus vectors and gene therapy.
Conclusion
Daniel J Von Seggern's contributions to the field of gene therapy through his patent and research at the Scripps Research Institute highlight his role as an influential inventor. His work continues to pave the way for advancements in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
